Effect of mycophenolate sodium in scleroderma-related interstitial lung disease

@article{SimenAznar2011EffectOM,
  title={Effect of mycophenolate sodium in scleroderma-related interstitial lung disease},
  author={Carmen Pilar Sime{\'o}n-Aznar and Vicent Fonollosa-Pl{\'a} and Carles Tolosa-Vilella and Albert Selva-O’Callaghan and Roser Solans-Laqu{\'e} and Miquel Vilardell-Tarr{\'e}s},
  journal={Clinical Rheumatology},
  year={2011},
  volume={30},
  pages={1393-1398}
}
This study aims to determine the effectiveness of mycophenolate sodium (MS) in patients with scleroderma (SSc)-related interstitial lung disease (ILD). In a prospective observational study, we evaluated 14 consecutive SSc-ILD patients who were treated with MS for 12 months. The effect of MS on lung function was examined by using longitudinal data analytic methods. Wilcoxon rank–sum tests were used to examine the forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1) and diffusing… CONTINUE READING